STUB1 and chronic myelogenous leukemia, BCR-ABL1 positive: The aim of this work was to determine the mutational profile of a series of CML patients and investigate the association between the presence of somatic myeloid mutations (including those with a reported role in CHIP) and the development of CVE on TKI treatment.